Aldevron News
CGT – The Right Tools for the Job
May 1, 2025 / by Aldevron
Cell and gene therapy manufacturing is like any production process. It requires specific tools and elements to ensure a safe, efficient and cost-effective product. As plasmids are a critical part of the production process, Aldevron is known as a leader in providing quality materials to support therapeutic development.
In “Improving CGT Production to Speed Delivery and Lower Costs,” from Genetic Engineering & Biotechnology News, Aldevron and its processes were highlighted as part of a focused discussion on how advances in the field are meeting the challenges in delivering life-changing therapeutics.
As Robert Reames, Aldevron Vice President of Technical Operations, pointed out in the article, there are three key challenges the company is meeting in the production process: scale, sequence complexity, and more stringent purification specifications.
Reames also expanded on how Aldevron provides solutions in those production elements and how the company optimized its processes to better serve clients.